Provention bio with Sanofi as its Marketing partner Grand long awaited FDA nod for "Teplizumab", a drug developed to combat juvenile diabetes
The immunotherapy, which delays the progression of type 1 diabetes, will be available to patients age 8 and older who are in stage 2 of the disorder. It becomes the first drug approved to delay progression of type 1 diabetes. https://www.fiercepharma.com/pharma/provention-bio-wins-long-awaited-fda-approval-type-1-diabetes-drug